Skip to content

European Transfusion Practice and Outcome Study

European Transfusion Practice and Outcome Study A Multi-central Evaluation of Standard of Transfusion Care and Clinical Outcome for Elective Surgical Patients. Observational Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01604083
Acronym
ETPOS
Enrollment
6066
Registered
2012-05-23
Start date
2013-04-30
Completion date
2013-12-31
Last updated
2019-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Blood Coagulation Disorders, Erythrocyte Transfusion, Habits, Surgery

Keywords

transfusion, packed red blood cells (PRBC), Transfusion Practice, Transfusion habits, Outcome, elective surgery, ETPOS, ESA, European Society of Anaesthesiology

Brief summary

The aim of the ETPOS study is to describe differences in transfusion habits throughout Europe and to correlate these habits to perioperative outcome parameters. Special focus is put on the number of PRBCs (packed red blood cells) transfused and the ratio of PRBCs to other blood products or coagulation factors in the operating room. Furthermore the motivation of physicians to transfuse PRBC and blood products in the operating room will be investigated.

Detailed description

In European patients undergoing elective non-cardiac surgery receiving at least one PRBC(packed red blood cells) during their surgery it is proposed to: 1. Evaluate evidence of differences in the standard of peri-operative transfusion care in different healthcare systems within Europe, and the use of blood conserving techniques. 1. Evaluate the ratio of transfusion of PRBC to blood products in the operating room 2. Evaluate which factors determine transfusion of PRBC (is it patient's haemodynamics / haemoglobin threshold/ pressure from the surgeon / acute brisk bleeding / else) and blood products (ratio to PRBC / POC (point of care) monitoring/ per protocol/ else) in the operating room 2. Evaluate whether there are factors in transfusion therapy that are associated with outcome (in-hospital mortality and unplanned admission to ICU(Intensive Care Unit).)

Interventions

None listed

Sponsors

European Society of Anaesthesiology
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- patients undergoing elective non-cardiac surgery commencing during the three-month period and who received at least one erythrocyte concentrate during their intra-operative stay.

Exclusion criteria

* Age \< 18 years * cardiothoracic surgery * emergency trauma patients

Design outcomes

Primary

MeasureTime frameDescription
Amount of PRBC and blood products and coagulation factors transfusedThe Time point at which outcome measure is assessed is during surgery at Day 0Amount of packed red blood cells and blood products and coagulation factors: fresh frozen plasmas (FFPs), platelets (PTs) and tranexamic acid transfused

Secondary

MeasureTime frameDescription
Unplanned admission to the ICUThe Time point at which outcome measure is assessed is at Day 30 after SurgeryAssesses on day 30 whether the patient had a Unplanned admission to the Intensive care unit(ICU) following surgery (day 0) until the day 30
Factors determining transfusion of PRBC and blood products in different regions of EuropeThe Time point at which outcome measure is assessed is during surgery at Day 0Reasons for transfusion of PRBC(packed red blood cells)and blood products in different regions of Europe
30-day mortalityThe Time point at which outcome measure is assessed is at Day 30 after SurgeryAssesses on Day 30 whether patient is still alive or has died between day zero (Surgery) day 30 after surgery
Type and frequency of usage of blood conserving techniquesThe Time point at which outcome measure is assessed is at Day 0, on Surgery Day

Countries

Croatia, Czechia, Estonia, Germany, Greece, Israel, Spain, Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026